We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
MYL6
HPA
RESOURCES
  • TISSUE
  • BRAIN
  • SINGLE CELL
  • SUBCELLULAR
  • CANCER
  • BLOOD
  • CELL LINE
  • STRUCTURE & INTERACTION
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Antibody panel
Tissue
Main location
Patient ID
Annotation
Tissue
Category
Tau score
Cluster
Reliability
Brain region
Category
Tau score
Brain region
Category
Tau score
Brain region
Category
Tau score
Cluster
Reliability
Tissue
Cell type
Enrichment
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell lineage
Category
Tau score
Cluster
Cluster
Location
Searches
Location
Cell line
Class
Type
Phase
Reliability
Cancer
Prognosis
Cancer
Category
Cancer
Category
Tau score
Cluster
Variants
Interacting gene (ensg_id)
Type
Number of interactions
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Data type
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • SUBCELL

  • CANCER

  • BLOOD

  • CELL LINE

  • STRUCT & INT

  • MYL6
CANCER LIVER CANCER Show tissue menu
BREAST CANCER CARCINOID CERVICAL CANCER COLORECTAL CANCER ENDOMETRIAL CANCER GLIOMA HEAD AND NECK CANCER LIVER CANCER LUNG CANCER LYMPHOMA
MELANOMA OVARIAN CANCER PANCREATIC CANCER PROSTATE CANCER RENAL CANCER SKIN CANCER STOMACH CANCER TESTIS CANCER THYROID CANCER UROTHELIAL CANCER
LIHC TCGA LIHC VALIDATION PROTEIN LIHC CPTAC PROTEIN EXPRESSION
ANTIBODIES
AND
VALIDATION
Dictionary
Liver cancer
Human cancer
Liver hepatocellular carcinoma
LIVER HEPATOCELLULAR CARCINOMA (TCGA) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

MYL6 is not prognostic in Liver Hepatocellular Carcinoma (TCGA)


Stage:


Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 945.97
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 1194.7
Number of samples 362
Samples
Sample Description pTPM
TCGA-G3-A25T-01A 45 years, female, white, stage:Stage IIIA, alive, 1553 days 4044.5
TCGA-G3-A25X-01A 73 years, male, asian, stage:Stage II, alive, 1779 days 3701.4
TCGA-UB-A7MA-01A 62 years, female, white, stage:Stage II, alive, 848 days 3171.4
TCGA-DD-A3A6-01A 72 years, female, white, stage:Stage II, dead, 3258 days 2917.0
TCGA-CC-5260-01A 61 years, female, asian, stage:Stage IIIC, dead, 87 days 2733.6
TCGA-DD-A73G-01A 73 years, female, white, stage:Stage I, alive, 3478 days 2706.3
TCGA-CC-A3M9-01A 45 years, male, asian, stage:Stage IIIA, dead, 300 days 2659.5
TCGA-YA-A8S7-01A 68 years, male, white, stage:Stage IIIA, dead, 412 days 2658.0
TCGA-PD-A5DF-01A 58 years, female, white, stage:Stage IIIB, dead, 639 days 2566.7
TCGA-DD-AA3A-01A 81 years, female, white, stage:Stage I, dead, 410 days 2498.1
TCGA-ED-A7PX-01A 48 years, female, asian, stage:Stage II, alive, 6 days 2430.0
TCGA-DD-A3A9-01A 64 years, female, white, stage:Stage IVB, dead, 931 days 2397.2
TCGA-CC-A7IJ-01A 56 years, male, asian, stage:Stage II, alive, 382 days 2390.3
TCGA-CC-A5UD-01A 45 years, male, asian, stage:Stage IIIA, dead, 304 days 2342.8
TCGA-FV-A4ZP-01A 78 years, male, white, stage:Stage IIIA, dead, 2486 days 2316.0
TCGA-FV-A3I0-01A 76 years, female, white, stage:Stage II, alive, 848 days 2303.8
TCGA-DD-AACI-01A 69 years, male, asian, stage:Stage II, alive, 1618 days 2271.6
TCGA-CC-A7IG-01A 47 years, male, asian, stage:Stage II, dead, 299 days 2240.9
TCGA-ED-A7PZ-01A 61 years, male, asian, stage:Stage II, alive, 6 days 2202.7
TCGA-CC-5264-01A 71 years, male, asian, stage:Stage IIIA, dead, 102 days 2111.6
TCGA-ED-A82E-01A 60 years, female, asian, stage:Stage IIIA, alive, 408 days 2104.4
TCGA-UB-A7MB-01A 24 years, male, white, stage:Stage II, alive, 601 days 2095.7
TCGA-DD-A4NA-01A 67 years, female, white, stage:Stage IIIC, alive, 1008 days 2091.6
TCGA-ED-A97K-01A 54 years, male, asian, stage:Stage IIIA, alive, 6 days 2059.1
TCGA-DD-A3A5-01A 66 years, female, white, stage:Stage III, dead, 3125 days 2020.7
TCGA-UB-A7MF-01A 56 years, male, white, stage:Stage IIIA, dead, 214 days 2019.1
TCGA-BC-A10Q-01A 72 years, female, white, stage:'--, dead, 1135 days 2011.3
TCGA-CC-A8HU-01A 39 years, female, asian, stage:Stage IIIA, dead, 344 days 1975.8
TCGA-ED-A7XO-01A 29 years, male, asian, stage:Stage IIIA, alive, 427 days 1963.9
TCGA-UB-A7ME-01A 51 years, male, asian, stage:Stage I, alive, 486 days 1946.1
TCGA-CC-A123-01A 24 years, female, asian, stage:Stage IIIA, alive, 219 days 1937.7
TCGA-2Y-A9H3-01A 45 years, male, white, stage:Stage II, alive, 1516 days 1923.0
TCGA-DD-A1EF-01A 57 years, female, white, stage:Stage I, dead, 394 days 1917.9
TCGA-RC-A7SK-01A 59 years, male, asian, stage:Stage I, alive, 472 days 1897.2
TCGA-DD-AADI-01A 43 years, female, asian, stage:Stage I, alive, 1085 days 1871.6
TCGA-CC-A1HT-01A 50 years, male, asian, stage:Stage IIIA, dead, 101 days 1866.0
TCGA-DD-AAVP-01A 48 years, male, asian, stage:Stage I, alive, 2752 days 1861.8
TCGA-FV-A495-01A 51 years, female, white, stage:Stage II, alive, 1 days 1834.4
TCGA-G3-AAV7-01A 38 years, male, asian, stage:Stage II, alive, 361 days 1830.9
TCGA-DD-AAE0-01A 45 years, female, asian, stage:Stage IIIA, alive, 555 days 1803.6
TCGA-K7-AAU7-01A 61 years, male, white, stage:Stage II, alive, 359 days 1798.2
TCGA-CC-A7II-01A 54 years, male, asian, stage:Stage IIIA, alive, 399 days 1796.9
TCGA-DD-AACB-01A 74 years, female, asian, stage:Stage I, alive, 2324 days 1781.2
TCGA-DD-AACO-01A 40 years, male, asian, stage:Stage I, alive, 1876 days 1757.8
TCGA-DD-AADS-01A 63 years, male, asian, stage:Stage I, alive, 474 days 1757.2
TCGA-G3-A25Y-01A 52 years, female, asian, stage:Stage I, dead, 452 days 1742.6
TCGA-DD-AAE4-01A 49 years, female, asian, stage:Stage I, alive, 608 days 1735.4
TCGA-G3-A5SI-01A 44 years, male, asian, stage:Stage II, dead, 768 days 1731.0
TCGA-G3-A7M6-01A 60 years, female, white, stage:Stage I, alive, 632 days 1720.9
TCGA-GJ-A3OU-01A 59 years, male, white, stage:Stage I, alive, 879 days 1691.2
TCGA-G3-AAV4-01A 83 years, female, white, stage:Stage I, dead, 27 days 1678.9
TCGA-BC-A3KF-01A 66 years, female, white, stage:Stage I, alive, 8 days 1678.6
TCGA-BC-A69H-01A 64 years, male, white, stage:Stage II, alive, 444 days 1638.7
TCGA-DD-A39V-01A 77 years, male, white, stage:Stage II, dead, 643 days 1633.1
TCGA-DD-A4NN-01A 56 years, female, white, stage:Stage I, dead, 899 days 1631.8
TCGA-BC-A5W4-01A 69 years, male, white, stage:Stage IIIA, dead, 547 days 1619.5
TCGA-DD-AAVS-01A 56 years, male, asian, stage:Stage I, alive, 1823 days 1589.6
TCGA-5C-A9VG-01A 58 years, male, white, stage:Stage II, alive, 328 days 1584.5
TCGA-DD-AAD5-01A 54 years, male, asian, stage:Stage I, alive, 1345 days 1582.9
TCGA-T1-A6J8-01A 68 years, male, white, stage:'--, alive, 23 days 1581.9
TCGA-G3-AAV6-01A 53 years, female, white, stage:Stage IIIA, dead, 65 days 1573.0
TCGA-DD-AADW-01A 48 years, male, asian, stage:Stage I, alive, 587 days 1570.1
TCGA-DD-AAE3-01A 50 years, male, asian, stage:Stage I, alive, 566 days 1569.6
TCGA-DD-A114-01A 42 years, male, black or african american, stage:Stage II, dead, 1149 days 1563.4
TCGA-CC-5262-01A 67 years, male, asian, stage:Stage IIIC, dead, 103 days 1559.9
TCGA-DD-AACF-01A 68 years, male, asian, stage:Stage I, dead, 365 days 1547.3
TCGA-DD-AAC8-01A 72 years, male, asian, stage:Stage I, dead, 16 days 1542.1
TCGA-KR-A7K8-01A 57 years, male, stage:Stage I, alive, 906 days 1535.0
TCGA-DD-A4NR-01A 85 years, female, white, stage:Stage I, dead, 9 days 1532.8
TCGA-DD-AACH-01A 69 years, male, asian, stage:Stage II, dead, 195 days 1532.0
TCGA-ED-A5KG-01A 60 years, female, asian, stage:Stage II, alive, 854 days 1522.3
TCGA-2Y-A9H4-01A 68 years, male, black or african american, stage:Stage I, alive, 1452 days 1514.7
TCGA-BC-A3KG-01A 68 years, female, white, stage:Stage II, alive, 680 days 1499.2
TCGA-CC-A5UE-01A 48 years, male, asian, stage:Stage IIIB, dead, 272 days 1496.8
TCGA-UB-A7MD-01A 67 years, male, black or african american, stage:Stage I, dead, 52 days 1486.6
TCGA-DD-AACU-01A 59 years, male, asian, stage:Stage I, alive, 1567 days 1482.1
TCGA-BC-A10S-01A 81 years, male, white, stage:'--, dead, 1423 days 1473.5
TCGA-DD-AADV-01A 50 years, male, asian, stage:Stage I, alive, 574 days 1471.7
TCGA-FV-A3I1-01A 81 years, female, white, stage:Stage II, dead, 247 days 1463.9
TCGA-5C-AAPD-01A 61 years, male, asian, stage:Stage II, alive, 20 days 1463.4
TCGA-DD-A118-01A 77 years, female, white, stage:Stage II, alive, 3437 days 1445.0
TCGA-G3-A7M5-01A 76 years, male, asian, stage:Stage I, alive, 447 days 1441.5
TCGA-ZS-A9CF-01A 64 years, male, white, stage:Stage II, alive, 2412 days 1437.8
TCGA-2Y-A9H0-01A 49 years, male, white, stage:Stage IIIA, alive, 3675 days 1436.0
TCGA-DD-A3A7-01A 67 years, male, stage:Stage IIIB, dead, 419 days 1434.5
TCGA-5C-A9VH-01A 70 years, male, white, stage:Stage I, alive, 322 days 1429.4
TCGA-DD-AACV-01A 53 years, male, asian, stage:Stage I, alive, 1531 days 1418.0
TCGA-DD-A4NH-01A 65 years, female, white, stage:Stage IIIB, alive, 917 days 1414.7
TCGA-G3-A25S-01A 64 years, male, white, stage:Stage I, dead, 416 days 1407.7
TCGA-DD-AACG-01A 52 years, male, asian, stage:Stage II, dead, 469 days 1395.8
TCGA-GJ-A9DB-01A 68 years, male, white, stage:Stage I, dead, 67 days 1389.9
TCGA-ES-A2HS-01A 80 years, male, white, stage:Stage I, dead, 688 days 1388.3
TCGA-DD-A39Y-01A 67 years, male, asian, stage:Stage I, dead, 171 days 1380.2
TCGA-ZP-A9D2-01A 51 years, male, white, stage:'--, dead, 765 days 1377.7
TCGA-G3-A7M9-01A 70 years, male, white, stage:Stage IIIB, dead, 56 days 1368.8
TCGA-BW-A5NO-01A 50 years, male, black or african american, stage:Stage IIIA, alive, 20 days 1363.4
TCGA-G3-A25Z-01A 58 years, male, asian, stage:Stage I, alive, 655 days 1357.0
TCGA-RC-A6M6-01A 75 years, male, white, stage:Stage II, alive, 9 days 1353.4
TCGA-UB-A7MC-01A 59 years, male, white, stage:Stage IIIA, alive, 500 days 1344.7
TCGA-BC-A217-01A 75 years, female, white, stage:Stage II, dead, 1397 days 1339.8
TCGA-KR-A7K2-01A 64 years, male, white, stage:Stage I, alive, 829 days 1336.4
TCGA-DD-A4ND-01A 56 years, female, white, stage:Stage I, alive, 2746 days 1330.4
TCGA-ED-A627-01A 74 years, male, white, stage:Stage I, alive, 423 days 1326.6
TCGA-4R-AA8I-01A 66 years, male, white, stage:Stage II, dead, 262 days 1325.9
TCGA-DD-A39X-01A 78 years, female, white, stage:Stage I, dead, 1694 days 1321.2
TCGA-DD-A1EI-01A 46 years, male, asian, stage:Stage I, alive, 183 days 1313.4
TCGA-DD-AAD0-01A 73 years, female, asian, stage:Stage I, alive, 137 days 1310.3
TCGA-CC-A9FW-01A 68 years, male, asian, stage:Stage IIIA, alive, 248 days 1308.8
TCGA-HP-A5N0-01A 90 years, female, stage:'--, dead, 752 days 1307.6
TCGA-DD-A73E-01A 66 years, male, white, stage:Stage I, alive, 44 days 1303.6
TCGA-DD-AAEE-01A 55 years, male, asian, stage:Stage I, alive, 810 days 1303.4
TCGA-DD-A113-01A 55 years, female, white, stage:Stage II, alive, 2425 days 1301.9
TCGA-BD-A2L6-01A 69 years, male, white, stage:'--, alive, 1363 days 1295.6
TCGA-2Y-A9H2-01A 64 years, female, white, stage:Stage I, alive, 1731 days 1294.2
TCGA-DD-AACZ-01A 63 years, female, asian, stage:Stage I, dead, 171 days 1291.2
TCGA-CC-A7IK-01A 59 years, male, asian, stage:Stage IIIA, dead, 262 days 1286.5
TCGA-DD-AADO-01A 55 years, male, asian, stage:Stage I, alive, 453 days 1286.1
TCGA-2Y-A9GS-01A 58 years, male, white, stage:'--, dead, 724 days 1281.6
TCGA-2Y-A9H6-01A 68 years, female, white, stage:Stage I, alive, 357 days 1280.6
TCGA-G3-A7M7-01A 65 years, male, white, stage:Stage I, alive, 361 days 1272.7
TCGA-MI-A75I-01A 61 years, male, black or african american, stage:'--, alive, 630 days 1268.8
TCGA-DD-A4NJ-01A 54 years, female, white, stage:Stage II, alive, 928 days 1266.9
TCGA-DD-AACP-01A 64 years, male, asian, stage:Stage I, alive, 415 days 1261.8
TCGA-GJ-A6C0-01A 75 years, female, white, stage:Stage II, dead, 31 days 1258.2
TCGA-CC-A3MA-01A 61 years, male, asian, stage:Stage IIIA, dead, 303 days 1256.0
TCGA-ED-A66X-01A 35 years, male, asian, stage:Stage IIIA, alive, 406 days 1251.4
TCGA-DD-A1EC-01A 20 years, female, white, stage:Stage I, alive, 602 days 1244.8
TCGA-WQ-AB4B-01A 62 years, male, white, stage:Stage II, alive, 395 days 1242.2
TCGA-DD-AAVR-01A 44 years, male, asian, stage:Stage I, alive, 2513 days 1240.6
TCGA-EP-A2KB-01A 46 years, female, white, stage:Stage I, dead, 596 days 1240.3
TCGA-G3-A5SM-01A 58 years, male, white, stage:Stage II, alive, 520 days 1229.5
TCGA-BC-A69I-01A 69 years, male, white, stage:Stage I, alive, 387 days 1229.1
TCGA-KR-A7K0-01A 65 years, male, white, stage:Stage I, dead, 65 days 1220.4
TCGA-CC-A7IH-01A 58 years, male, asian, stage:Stage IIIA, alive, 365 days 1218.8
TCGA-BC-A10Y-01A 76 years, male, white, stage:'--, dead, 711 days 1210.6
TCGA-DD-A119-01A 40 years, male, asian, stage:Stage IV, dead, 223 days 1209.9
TCGA-CC-5263-01A 35 years, male, asian, stage:Stage IIIA, dead, 129 days 1206.3
TCGA-G3-A5SJ-01A 59 years, male, white, stage:Stage I, alive, 698 days 1201.3
TCGA-DD-AADK-01A 68 years, female, asian, stage:Stage II, alive, 1049 days 1199.9
TCGA-3K-AAZ8-01A 65 years, male, black or african american, stage:Stage IIIB, alive, 396 days 1197.0
TCGA-BC-A112-01A 80 years, male, white, stage:'--, dead, 153 days 1187.9
TCGA-DD-AAE2-01A 51 years, male, asian, stage:Stage I, alive, 638 days 1174.4
TCGA-DD-AAEI-01A 72 years, male, asian, stage:Stage I, alive, 1531 days 1173.7
TCGA-DD-AAD3-01A 43 years, male, asian, stage:Stage I, alive, 1295 days 1170.0
TCGA-ES-A2HT-01A 54 years, male, black or african american, stage:Stage I, dead, 438 days 1169.8
TCGA-DD-AAVQ-01A 38 years, male, asian, stage:Stage I, alive, 2728 days 1163.1
TCGA-G3-AAUZ-01A 48 years, male, stage:Stage I, alive, 480 days 1157.5
TCGA-FV-A2QQ-01A 80 years, male, white, stage:Stage I, alive, 729 days 1157.4
TCGA-MI-A75H-01A 77 years, male, white, stage:'--, alive, 747 days 1156.8
TCGA-DD-AADM-01A 58 years, male, asian, stage:Stage II, dead, 12 days 1151.9
TCGA-DD-AAEG-01A 59 years, female, asian, stage:Stage I, alive, 719 days 1149.7
TCGA-5R-AA1C-01A 57 years, male, white, stage:Stage II, alive, 520 days 1145.8
TCGA-DD-AADJ-01A 70 years, female, asian, stage:Stage I, alive, 1066 days 1142.6
TCGA-DD-AACC-01A 61 years, male, asian, stage:Stage I, dead, 1685 days 1140.2
TCGA-CC-A3MB-01A 36 years, male, asian, stage:Stage IIIA, dead, 315 days 1139.5
TCGA-2Y-A9H5-01A 59 years, female, white, stage:Stage I, dead, 555 days 1137.9
TCGA-CC-5261-01A 44 years, male, asian, stage:Stage II, dead, 97 days 1137.8
TCGA-CC-A8HS-01A 18 years, male, asian, stage:Stage IIIC, dead, 300 days 1136.6
TCGA-DD-A116-01A 68 years, male, asian, stage:Stage IIIA, dead, 1622 days 1132.8
TCGA-MI-A75E-01A 61 years, male, white, stage:Stage IIIC, alive, 507 days 1131.5
TCGA-XR-A8TG-01A 58 years, male, white, stage:Stage I, alive, 898 days 1127.8
TCGA-DD-AAVV-01A 56 years, male, asian, stage:Stage II, alive, 2455 days 1126.9
TCGA-DD-A4NS-01A 61 years, female, white, stage:Stage I, dead, 2456 days 1124.3
TCGA-DD-AADD-01A 51 years, male, asian, stage:Stage I, alive, 1231 days 1122.6
TCGA-UB-AA0U-01A 60 years, male, white, stage:Stage II, alive, 327 days 1119.9
TCGA-DD-AACL-01A 66 years, female, asian, stage:Stage I, dead, 107 days 1119.1
TCGA-DD-AAW2-01A 69 years, male, asian, stage:Stage I, alive, 1855 days 1116.9
TCGA-BD-A3EP-01A 75 years, female, black or african american, stage:Stage I, alive, 409 days 1110.7
TCGA-DD-AAVZ-01A 38 years, male, asian, stage:Stage I, alive, 1900 days 1108.3
TCGA-ZS-A9CD-01A 73 years, male, white, stage:Stage II, dead, 1386 days 1104.2
TCGA-MI-A75G-01A 63 years, male, white, stage:Stage II, alive, 698 days 1104.0
TCGA-FV-A3R2-01A 75 years, male, white, stage:Stage I, dead, 194 days 1102.4
TCGA-WQ-A9G7-01A 71 years, female, white, stage:'--, alive, 30 days 1099.4
TCGA-G3-AAV0-01A 58 years, male, asian, stage:Stage I, alive, 476 days 1099.0
TCGA-XR-A8TD-01A 49 years, female, white, stage:Stage IIIB, alive, 1030 days 1098.9
TCGA-ZP-A9CZ-01A 72 years, male, asian, stage:'--, alive, 706 days 1098.6
TCGA-DD-A1EH-01A 23 years, male, white, stage:Stage III, alive, 1495 days 1093.0
TCGA-DD-A3A1-01A 65 years, male, stage:Stage IIIA, dead, 233 days 1087.9
TCGA-DD-AADC-01A 53 years, male, asian, stage:Stage I, dead, 425 days 1076.9
TCGA-G3-AAV2-01A 50 years, male, white, stage:Stage I, alive, 372 days 1076.6
TCGA-DD-A11B-01A 73 years, male, white, stage:Stage I, dead, 14 days 1075.5
TCGA-DD-A4NB-01A 25 years, male, white, stage:Stage I, alive, 989 days 1070.6
TCGA-2Y-A9HA-01A 70 years, male, white, stage:Stage II, dead, 36 days 1069.9
TCGA-DD-AACN-01A 32 years, male, asian, stage:Stage I, alive, 1302 days 1065.0
TCGA-DD-A1EL-01A 23 years, male, black or african american, stage:Stage II, dead, 415 days 1060.1
TCGA-DD-AAVW-01A 35 years, male, asian, stage:Stage I, alive, 2317 days 1058.8
TCGA-K7-A6G5-01A 66 years, male, white, stage:Stage I, alive, 512 days 1053.5
TCGA-DD-A4NE-01A 75 years, female, white, stage:Stage IIIA, dead, 660 days 1052.1
TCGA-DD-A11D-01A 57 years, female, white, stage:Stage I, dead, 1560 days 1048.8
TCGA-DD-AADF-01A 64 years, female, asian, stage:Stage I, dead, 115 days 1046.8
TCGA-2Y-A9GY-01A 64 years, female, white, stage:Stage II, dead, 757 days 1045.9
TCGA-ZP-A9CY-01A 66 years, female, white, stage:'--, alive, 782 days 1044.4
TCGA-RG-A7D4-01A 69 years, male, black or african american, stage:Stage II, alive, 1098 days 1043.2
TCGA-DD-A4NQ-01A 60 years, male, white, stage:Stage II, dead, 373 days 1042.5
TCGA-ZS-A9CG-01A 55 years, male, white, stage:Stage II, alive, 341 days 1042.1
TCGA-FV-A2QR-01A 75 years, male, white, stage:Stage I, dead, 581 days 1041.3
TCGA-2Y-A9H9-01A 70 years, male, white, stage:Stage I, alive, 697 days 1041.1
TCGA-EP-A3RK-01A 73 years, male, white, stage:Stage IIIA, alive, 363 days 1038.6
TCGA-2Y-A9H8-01A 85 years, female, white, stage:'--, dead, 633 days 1037.7
TCGA-DD-A73B-01A 72 years, female, white, stage:Stage I, dead, 283 days 1037.2
TCGA-G3-A25V-01A 68 years, male, white, stage:Stage I, alive, 860 days 1034.9
TCGA-DD-AADG-01A 70 years, male, asian, stage:Stage IIIA, alive, 1145 days 1029.7
TCGA-DD-A1EG-01A 76 years, male, white, stage:Stage I, dead, 1372 days 1026.9
TCGA-DD-AAD1-01A 51 years, female, asian, stage:Stage I, alive, 564 days 1023.0
TCGA-KR-A7K7-01A 61 years, female, white, stage:Stage II, alive, 951 days 1021.6
TCGA-RC-A6M4-01A 74 years, female, white, stage:Stage IIIA, alive, 22 days 1020.8
TCGA-BC-A110-01A 51 years, female, black or african american, stage:'--, dead, 2116 days 1019.4
TCGA-O8-A75V-01A 54 years, male, stage:Stage I, alive, 538 days 1015.7
TCGA-FV-A4ZQ-01A 52 years, male, white, stage:Stage I, alive, 12 days 1014.2
TCGA-XR-A8TF-01A 74 years, male, white, stage:Stage I, dead, 693 days 1013.9
TCGA-LG-A9QC-01A 48 years, male, white, stage:Stage I, alive, 425 days 1012.7
TCGA-2Y-A9HB-01A 66 years, male, stage:Stage I, alive, 260 days 1006.1
TCGA-MR-A8JO-01A 34 years, male, white, stage:Stage I, alive, 330 days 1004.5
TCGA-DD-A3A3-01A 45 years, male, asian, stage:Stage I, dead, 535 days 1004.4
TCGA-DD-AAC9-01A 51 years, male, asian, stage:Stage I, alive, 347 days 1002.1
TCGA-RC-A6M5-01A 20 years, female, white, stage:Stage IVA, alive, 15 days 995.6
TCGA-FV-A23B-01A 70 years, female, white, stage:Stage II, dead, 1852 days 994.2
TCGA-DD-AAW0-01A 54 years, male, asian, stage:Stage I, alive, 2015 days 994.1
TCGA-ED-A459-01A 47 years, male, asian, stage:Stage II, alive, 910 days 992.6
TCGA-2Y-A9GW-01A 64 years, male, white, stage:Stage I, dead, 1271 days 992.4
TCGA-DD-AAW3-01A 69 years, male, asian, stage:Stage I, alive, 1633 days 991.6
TCGA-BC-A10T-01A 76 years, male, white, stage:'--, dead, 837 days 990.7
TCGA-DD-AACS-01A 39 years, male, asian, stage:Stage I, alive, 1804 days 983.4
TCGA-BC-A10Z-01A 62 years, female, white, stage:Stage I, dead, 34 days 979.0
TCGA-WX-AA44-01A 64 years, female, white, stage:Stage I, alive, 615 days 974.3
TCGA-DD-A73F-01A 77 years, female, white, stage:Stage I, alive, 1085 days 971.7
TCGA-G3-AAV3-01A 58 years, female, white, stage:Stage II, alive, 412 days 958.5
TCGA-FV-A3R3-01A 38 years, female, white, stage:Stage I, dead, 366 days 953.8
TCGA-DD-AADY-01A 55 years, female, asian, stage:Stage I, alive, 555 days 952.9
TCGA-BC-A10U-01A 69 years, male, white, stage:'--, dead, 837 days 952.0
TCGA-K7-A5RF-01A 64 years, male, white, stage:Stage I, alive, 631 days 950.4
TCGA-DD-A115-01A 53 years, male, white, stage:Stage IIIA, dead, 2542 days 947.8
TCGA-CC-A5UC-01A 63 years, male, asian, stage:Stage IIIA, dead, 347 days 946.1
TCGA-G3-A25U-01A 63 years, female, asian, stage:Stage I, alive, 1636 days 945.8
TCGA-DD-AADB-01A 51 years, male, asian, stage:Stage I, alive, 1242 days 942.0
TCGA-DD-AACW-01A 43 years, male, asian, stage:Stage I, alive, 1424 days 937.9
TCGA-BC-A10W-01A 50 years, male, asian, stage:'--, dead, 91 days 936.2
TCGA-DD-AACY-01A 61 years, male, asian, stage:Stage I, alive, 1450 days 932.7
TCGA-DD-A11C-01A 69 years, male, white, stage:Stage I, alive, 662 days 931.2
TCGA-DD-A4NK-01A 80 years, female, white, stage:Stage IIIA, dead, 1210 days 929.8
TCGA-ZP-A9D0-01A 67 years, female, black or african american, stage:'--, alive, 1091 days 929.6
TCGA-G3-A6UC-01A 65 years, male, white, stage:Stage IIIB, alive, 671 days 921.4
TCGA-RC-A7SH-01A 42 years, male, asian, stage:Stage II, alive, 468 days 920.8
TCGA-QA-A7B7-01A 48 years, male, black or african american, stage:Stage II, alive, 94 days 915.5
TCGA-ED-A7PY-01A 20 years, female, asian, stage:Stage II, alive, 390 days 909.9
TCGA-2Y-A9H1-01A 58 years, male, white, stage:Stage I, dead, 1229 days 909.8
TCGA-DD-AAEK-01A 51 years, male, asian, stage:Stage II, alive, 1067 days 909.7
TCGA-DD-A1EJ-01A 71 years, female, white, stage:Stage IIIC, dead, 1005 days 909.0
TCGA-DD-AADQ-01A 59 years, male, asian, stage:Stage II, alive, 436 days 908.6
TCGA-DD-AAVY-01A 56 years, male, asian, stage:Stage IIIA, alive, 1970 days 907.7
TCGA-2Y-A9H7-01A 81 years, female, white, stage:Stage I, alive, 1168 days 904.8
TCGA-5R-AA1D-01A 17 years, female, white, stage:Stage IIIA, alive, 449 days 900.4
TCGA-BC-A8YO-01A 66 years, female, white, stage:Stage IIIC, alive, 562 days 900.1
TCGA-2Y-A9GX-01A 68 years, male, white, stage:Stage I, alive, 2442 days 894.3
TCGA-DD-A39W-01A 29 years, female, white, stage:Stage III, dead, 827 days 894.0
TCGA-DD-AACX-01A 66 years, male, asian, stage:Stage II, alive, 170 days 889.9
TCGA-2Y-A9GT-01A 51 years, male, white, stage:Stage I, dead, 1624 days 883.9
TCGA-NI-A4U2-01A 71 years, male, white, stage:Stage IIIA, dead, 1791 days 883.4
TCGA-HP-A5MZ-01A 78 years, male, stage:Stage I, dead, 91 days 882.4
TCGA-EP-A3JL-01A 76 years, male, white, stage:Stage I, alive, 303 days 882.4
TCGA-DD-AAD2-01A 66 years, male, asian, stage:Stage I, alive, 658 days 879.8
TCGA-G3-A7M8-01A 31 years, male, asian, stage:Stage I, alive, 430 days 878.6
TCGA-G3-A3CK-01A 61 years, male, asian, stage:Stage I, alive, 585 days 878.4
TCGA-DD-AADL-01A 58 years, male, asian, stage:Stage I, alive, 636 days 872.5
TCGA-DD-AACD-01A 48 years, male, asian, stage:Stage I, dead, 381 days 871.2
TCGA-CC-A7IL-01A 61 years, male, asian, stage:Stage IIIA, dead, 278 days 870.8
TCGA-G3-AAV5-01A 67 years, male, white, stage:Stage II, alive, 354 days 861.6
TCGA-2Y-A9GU-01A 55 years, female, white, stage:Stage I, alive, 1939 days 860.4
TCGA-ZS-A9CE-01A 79 years, female, white, stage:Stage II, alive, 1241 days 859.5
TCGA-G3-A3CG-01A 80 years, male, white, stage:Stage I, alive, 673 days 856.4
TCGA-DD-A39Z-01A 43 years, female, stage:Stage II, dead, 601 days 850.3
TCGA-DD-AACK-01A 70 years, male, asian, stage:Stage I, alive, 9 days 849.5
TCGA-DD-A4NV-01A 61 years, male, white, stage:Stage IIIA, alive, 2398 days 849.5
TCGA-G3-A5SL-01A 70 years, male, white, stage:Stage II, alive, 621 days 844.2
TCGA-DD-AADR-01A 58 years, male, asian, stage:Stage I, alive, 2028 days 841.3
TCGA-DD-A3A8-01A 75 years, male, white, stage:Stage II, dead, 11 days 841.3
TCGA-DD-AADP-01A 45 years, male, asian, stage:Stage I, alive, 458 days 841.0
TCGA-XR-A8TC-01A 43 years, female, white, stage:Stage I, alive, 1339 days 840.6
TCGA-5R-AAAM-01A 65 years, female, white, stage:Stage II, dead, 46 days 839.8
TCGA-CC-A8HV-01A 51 years, female, asian, stage:Stage II, dead, 279 days 838.4
TCGA-DD-AAW1-01A 55 years, male, asian, stage:Stage IIIA, alive, 1989 days 837.3
TCGA-ED-A8O5-01A 59 years, female, asian, stage:Stage IIIA, alive, 406 days 835.7
TCGA-ZP-A9CV-01A 59 years, male, white, stage:'--, dead, 1088 days 827.6
TCGA-UB-AA0V-01A 69 years, female, white, stage:Stage I, alive, 314 days 822.7
TCGA-DD-AACA-01A 65 years, male, asian, stage:Stage I, alive, 2301 days 821.6
TCGA-CC-5258-01A 48 years, male, asian, stage:Stage II, dead, 129 days 820.3
TCGA-DD-AAVU-01A 46 years, male, asian, stage:Stage II, alive, 2202 days 813.5
TCGA-LG-A9QD-01A 68 years, male, white, stage:Stage IIIA, alive, 366 days 813.4
TCGA-DD-AAEA-01A 65 years, male, asian, stage:Stage I, alive, 575 days 812.8
TCGA-2Y-A9GV-01A 54 years, female, white, stage:Stage I, dead, 2532 days 812.1
TCGA-DD-AACQ-01A 50 years, male, asian, stage:Stage II, dead, 432 days 810.4
TCGA-DD-AAE9-01A 69 years, male, asian, stage:Stage I, alive, 722 days 810.3
TCGA-DD-AAE7-01A 72 years, male, asian, stage:Stage I, alive, 644 days 808.5
TCGA-ED-A7XP-01A 53 years, female, asian, stage:Stage II, alive, 400 days 808.1
TCGA-MI-A75C-01A 64 years, male, white, stage:Stage I, alive, 291 days 805.1
TCGA-RC-A7S9-01A 47 years, female, asian, stage:Stage I, alive, 640 days 804.7
TCGA-WX-AA46-01A 61 years, male, white, stage:Stage II, alive, 756 days 798.9
TCGA-RC-A7SB-01A 53 years, male, asian, stage:Stage II, alive, 588 days 796.2
TCGA-BC-A10X-01A 52 years, female, white, stage:Stage IIIA, dead, 770 days 795.9
TCGA-DD-AAEH-01A 73 years, male, asian, stage:Stage I, alive, 784 days 795.1
TCGA-DD-A1EB-01A 72 years, female, stage:Stage I, alive, 2017 days 790.3
TCGA-ZP-A9D4-01A 64 years, female, white, stage:'--, alive, 395 days 788.1
TCGA-EP-A26S-01A 70 years, male, white, stage:Stage I, alive, 608 days 786.7
TCGA-K7-A5RG-01A 66 years, male, black or african american, stage:Stage I, alive, 519 days 772.8
TCGA-EP-A2KA-01A 52 years, female, white, stage:Stage IIIA, dead, 627 days 772.5
TCGA-G3-A3CJ-01A 52 years, male, american indian or alaska native, stage:Stage II, alive, 594 days 770.7
TCGA-FV-A496-01A 84 years, female, white, stage:Stage I, alive, 10 days 763.9
TCGA-CC-A7IF-01A 59 years, male, asian, stage:Stage IIIA, dead, 649 days 761.0
TCGA-DD-AACT-01A 69 years, female, asian, stage:Stage I, alive, 1562 days 754.7
TCGA-ED-A8O6-01A 50 years, female, asian, stage:Stage IIIA, dead, 56 days 753.6
TCGA-G3-A3CH-01A 53 years, male, asian, stage:Stage IIIA, alive, 780 days 752.8
TCGA-DD-A3A2-01A 76 years, female, white, stage:Stage I, dead, 2131 days 752.6
TCGA-G3-AAV1-01A 51 years, male, asian, stage:Stage IIIC, dead, 359 days 749.0
TCGA-DD-A1EE-01A 73 years, male, white, stage:Stage IIIA, dead, 349 days 743.5
TCGA-BC-A10R-01A 66 years, female, white, stage:'--, dead, 308 days 743.2
TCGA-DD-A73C-01A 65 years, female, white, stage:Stage IIIA, alive, 701 days 740.6
TCGA-ED-A4XI-01A 58 years, male, asian, stage:Stage II, alive, 819 days 737.4
TCGA-CC-5259-01A 60 years, female, asian, stage:Stage IIIC, alive, 250 days 730.5
TCGA-DD-AACJ-01A 75 years, male, asian, stage:Stage II, alive, 2102 days 721.6
TCGA-DD-AAVX-01A 38 years, male, asian, stage:Stage II, alive, 1718 days 720.0
TCGA-CC-A9FS-01A 55 years, male, asian, stage:Stage II, alive, 211 days 719.0
TCGA-BD-A3ER-01A 62 years, male, white, stage:Stage II, alive, 1115 days 717.5
TCGA-MR-A520-01A 58 years, male, white, stage:Stage I, alive, 229 days 716.3
TCGA-XR-A8TE-01A 16 years, male, white, stage:Stage IIIA, alive, 925 days 713.4
TCGA-2Y-A9GZ-01A 82 years, female, white, stage:Stage II, dead, 848 days 713.2
TCGA-DD-A4NI-01A 67 years, male, white, stage:Stage II, alive, 816 days 713.0
TCGA-DD-AAE1-01A 52 years, male, asian, stage:Stage I, alive, 552 days 713.0
TCGA-DD-A4NF-01A 72 years, male, white, stage:Stage I, alive, 942 days 708.8
TCGA-EP-A2KC-01A 62 years, male, black or african american, stage:Stage I, dead, 19 days 700.9
TCGA-ZP-A9D1-01A 56 years, female, white, stage:'--, alive, 21 days 699.2
TCGA-EP-A12J-01A 62 years, male, black or african american, stage:Stage I, alive, 570 days 698.5
TCGA-ED-A66Y-01A 51 years, female, asian, stage:Stage IIIA, dead, 296 days 689.5
TCGA-DD-A1ED-01A 68 years, male, white, stage:Stage I, alive, 2301 days 686.8
TCGA-LG-A6GG-01A 79 years, female, white, stage:Stage II, alive, 387 days 686.3
TCGA-DD-A4NG-01A 77 years, male, white, stage:Stage IIIA, dead, 802 days 685.9
TCGA-DD-A73A-01A 71 years, male, white, stage:Stage I, alive, 728 days 685.7
TCGA-DD-AAD8-01A 73 years, female, asian, stage:Stage I, alive, 1219 days 672.4
TCGA-CC-A3MC-01A 54 years, male, asian, stage:Stage IIIA, alive, 363 days 664.9
TCGA-G3-A3CI-01A 71 years, male, white, stage:Stage I, alive, 180 days 663.1
TCGA-DD-A4NP-01A 32 years, male, white, stage:Stage I, alive, 3308 days 656.2
TCGA-DD-AADN-01A 59 years, male, asian, stage:Stage I, alive, 898 days 654.9
TCGA-NI-A8LF-01A 74 years, male, white, stage:Stage I, alive, 799 days 653.6
TCGA-BC-A216-01A 62 years, female, white, stage:Stage IIIA, alive, 1351 days 649.0
TCGA-G3-A5SK-01A 58 years, male, white, stage:Stage I, alive, 744 days 643.1
TCGA-DD-A73D-01A 68 years, female, white, stage:Stage II, alive, 693 days 637.8
TCGA-RC-A7SF-01A 66 years, male, asian, stage:Stage I, alive, 579 days 620.9
TCGA-DD-A3A4-01A 37 years, male, white, stage:Stage IIIA, dead, 612 days 608.2
TCGA-DD-A1EA-01A 68 years, male, asian, stage:Stage II, alive, 2415 days 601.2
TCGA-DD-AAE6-01A 59 years, female, asian, stage:Stage I, alive, 141 days 588.2
TCGA-DD-AADA-01A 66 years, female, asian, stage:Stage I, alive, 1233 days 586.6
TCGA-DD-A4NO-01A 65 years, male, white, stage:Stage I, alive, 2245 days 581.2
TCGA-DD-A1EK-01A 64 years, female, white, stage:Stage IVB, dead, 558 days 574.3
TCGA-DD-AADU-01A 60 years, male, asian, stage:Stage II, alive, 554 days 568.1
TCGA-DD-A4NL-01A 46 years, male, white, stage:Stage I, alive, 1711 days 538.9
TCGA-CC-A7IE-01A 57 years, male, asian, stage:Stage IIIA, dead, 217 days 532.4
TCGA-DD-AACE-01A 62 years, male, asian, stage:Stage I, alive, 2184 days 519.2
TCGA-CC-A8HT-01A 74 years, male, asian, stage:Stage IIIA, dead, 140 days 506.3
TCGA-DD-AAEB-01A 60 years, male, asian, stage:Stage I, alive, 478 days 494.8
TCGA-WX-AA47-01A 33 years, female, white, stage:Stage IIIA, dead, 556 days 413.5
TCGA-WJ-A86L-01A 68 years, female, white, stage:Stage I, alive, 345 days 397.4
TCGA-DD-AAED-01A 51 years, male, asian, stage:Stage I, alive, 763 days 386.9
TCGA-DD-AAD6-01A 66 years, male, asian, stage:Stage IIIA, alive, 672 days 292.6
Show allShow less
LIVER HEPATOCELLULAR CARCINOMA (VALIDATION) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

MYL6 is not prognostic in Liver Hepatocellular Carcinoma (validation)


Stage:
Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 1613.73
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 1286.6
Number of samples 231
Samples
Sample Description pTPM
DO45307 54 years, female, NA, stage:4, dead, 240 days 4558.9
DO48747 62 years, male, NA, stage:3, alive, 540 days 4349.9
DO45305 66 years, male, NA, stage:4, alive, 300 days 3933.8
DO45285 59 years, male, NA, stage:3, alive, 480 days 3809.6
DO45297 61 years, female, NA, stage:4, dead, 1260 days 3682.7
DO45289 78 years, female, NA, stage:3, alive, 360 days 3657.0
DO45301 56 years, male, NA, stage:2, dead, 1440 days 3411.5
DO45249 57 years, male, NA, stage:1, alive, 630 days 3253.7
DO45275 65 years, male, NA, stage:3, dead, 10 days 3121.5
DO45303 62 years, female, NA, stage:3, alive, 990 days 3021.2
DO50829 78 years, male, NA, stage:3, alive, 570 days 2835.2
DO23530 53 years, male, NA, stage:4, dead, 180 days 2767.4
DO45211 76 years, male, NA, stage:3, alive, 240 days 2702.2
DO48697 64 years, female, NA, stage:2, dead, 810 days 2521.6
DO45299 70 years, female, NA, stage:1, alive, 1440 days 2469.8
DO50800 74 years, male, NA, stage:2, alive, 510 days 2385.8
DO23523 52 years, male, NA, stage:3, alive, 1080 days 2343.2
DO45263 67 years, male, NA, stage:3, dead, 270 days 2237.6
DO45185 89 years, male, NA, stage:2, alive, 600 days 2196.9
DO48717 54 years, male, NA, stage:4, dead, 180 days 2191.5
DO23519 65 years, male, NA, stage:3, alive, 630 days 2180.3
DO48723 73 years, male, NA, stage:1, alive, 600 days 2169.6
DO45287 74 years, male, NA, stage:1, alive, 390 days 2158.9
DO45139 63 years, male, NA, stage:3, alive, 1320 days 2120.5
DO45135 77 years, male, NA, stage:1, alive, 1410 days 2101.7
DO48759 73 years, male, NA, stage:3, alive, 720 days 2041.9
DO45261 74 years, male, NA, stage:3, alive, 990 days 1976.8
DO48712 50 years, male, NA, stage:2, alive, 810 days 1965.3
DO50819 72 years, female, NA, stage:2, alive, 510 days 1961.7
DO50778 60 years, male, NA, stage:4, alive, 630 days 1928.4
DO50783 62 years, male, NA, stage:3, alive, 480 days 1815.0
DO45119 74 years, male, NA, stage:3, dead, 510 days 1814.3
DO23515 71 years, male, NA, stage:2, alive, 1230 days 1798.3
DO45277 64 years, male, NA, stage:3, alive, 600 days 1797.0
DO45251 57 years, female, NA, stage:2, alive, 900 days 1783.5
DO50839 47 years, female, NA, stage:3, alive, 330 days 1772.9
DO45245 75 years, female, NA, stage:2, dead, 240 days 1772.0
DO50809 56 years, male, NA, stage:3, dead, 720 days 1770.8
DO45189 85 years, female, NA, stage:2, alive, 1200 days 1765.3
DO45179 78 years, female, NA, stage:2, alive, 600 days 1748.5
DO50785 37 years, male, NA, stage:4, dead, 90 days 1736.6
DO48720 62 years, female, NA, stage:2, alive, 570 days 1731.2
DO23526 66 years, male, NA, stage:3, alive, 1050 days 1729.1
DO45279 67 years, male, NA, stage:3, alive, 1290 days 1717.4
DO23552 80 years, female, NA, stage:1, alive, 810 days 1676.3
DO23545 67 years, male, NA, stage:2, dead, 570 days 1674.0
DO23537 79 years, male, NA, stage:2, dead, 900 days 1665.7
DO23524 71 years, female, NA, stage:2, alive, 1050 days 1641.4
DO45205 67 years, female, NA, stage:2, dead, 90 days 1638.1
DO48732 73 years, male, NA, stage:3, alive, 630 days 1619.5
DO48761 55 years, male, NA, stage:2, alive, 870 days 1617.0
DO45092 62 years, male, NA, stage:4, dead, 1200 days 1613.7
DO48742 76 years, male, NA, stage:2, alive, 600 days 1606.5
DO50805 72 years, male, NA, stage:2, alive, 690 days 1604.7
DO50776 75 years, male, NA, stage:1, alive, 690 days 1595.2
DO50855 47 years, male, NA, stage:2, alive, 570 days 1581.0
DO45155 69 years, male, NA, stage:2, alive, 2160 days 1574.5
DO45097 69 years, male, NA, stage:3, alive, 1620 days 1573.4
DO48741 64 years, male, NA, stage:3, alive, 240 days 1558.3
DO23513 76 years, male, NA, stage:3, alive, 1200 days 1554.2
DO50806 70 years, male, NA, stage:4, alive, 540 days 1513.9
DO45165 75 years, male, NA, stage:2, alive, 690 days 1503.5
DO45127 73 years, male, NA, stage:3, dead, 420 days 1486.6
DO45121 61 years, male, NA, stage:3, alive, 1530 days 1479.6
DO50802 49 years, male, NA, stage:2, alive, 930 days 1477.5
DO23535 67 years, male, NA, stage:1, alive, 960 days 1472.8
DO23508 79 years, female, NA, stage:2, alive, 390 days 1466.4
DO45207 68 years, male, NA, stage:1, alive, 1050 days 1458.0
DO45273 62 years, male, NA, stage:2, alive, 480 days 1446.7
DO48681 57 years, male, NA, stage:2, alive, 900 days 1438.3
DO50832 73 years, male, NA, stage:3, alive, 90 days 1435.6
DO48728 74 years, female, NA, stage:2, alive, 150 days 1434.4
DO45283 60 years, male, NA, stage:3, alive, 510 days 1432.7
DO48736 76 years, female, NA, stage:1, alive, 600 days 1413.5
DO50787 63 years, male, NA, stage:3, alive, 480 days 1399.0
DO48757 68 years, female, NA, stage:3, alive, 480 days 1393.9
DO48672 81 years, male, NA, stage:2, alive, 450 days 1390.7
DO45095 66 years, male, NA, stage:2, alive, 1620 days 1381.4
DO23525 71 years, male, NA, stage:4, alive, 1050 days 1376.7
DO50813 56 years, male, NA, stage:2, alive, 420 days 1346.7
DO45103 47 years, male, NA, stage:3, alive, 450 days 1343.2
DO48695 77 years, male, NA, stage:2, alive, 720 days 1337.1
DO45161 74 years, male, NA, stage:2, dead, 540 days 1330.4
DO45145 78 years, male, NA, stage:3, dead, 60 days 1327.9
DO45109 63 years, male, NA, stage:2, alive, 1590 days 1312.7
DO45157 62 years, male, NA, stage:2, alive, 1980 days 1310.1
DO23547 74 years, male, NA, stage:1, alive, 1020 days 1305.1
DO48715 58 years, female, NA, stage:2, dead, 690 days 1305.0
DO45231 84 years, male, NA, stage:2, alive, 930 days 1300.9
DO50818 65 years, male, NA, stage:2, alive, 510 days 1297.8
DO45096 69 years, male, NA, stage:2, dead, 1290 days 1291.3
DO45141 73 years, male, NA, stage:2, alive, 1320 days 1271.1
DO45153 77 years, female, NA, stage:2, alive, 1380 days 1264.3
DO48719 80 years, male, NA, stage:2, alive, 690 days 1257.6
DO45259 65 years, male, NA, stage:3, alive, 330 days 1246.7
DO45255 81 years, male, NA, stage:3, alive, 720 days 1236.4
DO45177 81 years, female, NA, stage:3, alive, 1260 days 1224.7
DO48700 78 years, female, NA, stage:2, alive, 810 days 1219.5
DO50820 77 years, female, NA, stage:3, alive, 510 days 1219.3
DO45233 83 years, male, NA, stage:3, alive, 900 days 1215.7
DO45225 69 years, male, NA, stage:1, alive, 1050 days 1192.5
DO45267 73 years, male, NA, stage:3, dead, 570 days 1190.4
DO45221 75 years, female, NA, stage:4, dead, 390 days 1185.3
DO23542 66 years, male, NA, stage:3, alive, 960 days 1182.7
DO45253 50 years, male, NA, stage:2, alive, 870 days 1180.4
DO45209 70 years, male, NA, stage:4, alive, 1350 days 1174.1
DO50807 67 years, male, NA, stage:1, alive, 540 days 1168.1
DO23529 72 years, male, NA, stage:4, alive, 930 days 1162.8
DO45187 32 years, female, NA, stage:1, alive, 1260 days 1159.6
DO23510 80 years, female, NA, stage:2, alive, 870 days 1148.1
DO45223 67 years, male, NA, stage:4, alive, 1020 days 1141.9
DO45159 65 years, male, NA, stage:3, alive, 1470 days 1127.7
DO48743 69 years, female, NA, stage:2, alive, 570 days 1110.7
DO50798 77 years, male, NA, stage:3, dead, 30 days 1107.0
DO48730 73 years, female, NA, stage:2, alive, 630 days 1104.7
DO23528 45 years, female, NA, stage:2, alive, 1020 days 1091.9
DO48679 72 years, male, NA, stage:2, alive, 1200 days 1084.8
DO50789 73 years, female, NA, stage:2, alive, 570 days 1081.2
DO23550 69 years, male, NA, stage:1, alive, 990 days 1071.3
DO50811 62 years, male, NA, stage:1, alive, 450 days 1071.1
DO23514 64 years, male, NA, stage:2, alive, 1290 days 1068.5
DO45183 72 years, female, NA, stage:2, dead, 570 days 1066.1
DO45213 58 years, male, NA, stage:1, alive, 1200 days 1063.3
DO50808 68 years, male, NA, stage:2, alive, 570 days 1062.2
DO48701 78 years, male, NA, stage:2, alive, 780 days 1056.9
DO45143 69 years, male, NA, stage:3, alive, 1290 days 1056.5
DO45129 61 years, male, NA, stage:3, alive, 1470 days 1050.2
DO50791 79 years, female, NA, stage:1, dead, 480 days 1037.8
DO23518 67 years, male, NA, stage:2, alive, 1320 days 1037.3
DO45269 59 years, male, NA, stage:3, alive, 750 days 1030.7
DO45111 74 years, male, NA, stage:2, alive, 1590 days 1020.7
DO45219 78 years, male, NA, stage:2, alive, 1080 days 1015.5
DO45237 58 years, male, NA, stage:2, alive, 900 days 1014.8
DO45115 81 years, male, NA, stage:2, alive, 840 days 1010.3
DO23509 60 years, male, NA, stage:3, dead, 780 days 1007.5
DO50840 49 years, male, NA, stage:2, alive, 330 days 1004.8
DO23533 61 years, male, NA, stage:2, alive, 900 days 1004.5
DO45281 83 years, male, NA, stage:4, alive, 750 days 1003.0
DO23516 69 years, male, NA, stage:3, dead, 20 days 1000.4
DO23521 63 years, male, NA, stage:3, alive, 1110 days 986.6
DO45243 74 years, female, NA, stage:3, alive, 930 days 985.9
DO45199 86 years, female, NA, stage:2, alive, 1350 days 969.9
DO48677 58 years, male, NA, stage:3, alive, 1140 days 955.8
DO45203 71 years, female, NA, stage:2, alive, 1170 days 954.2
DO48725 66 years, male, NA, stage:1, alive, 780 days 948.7
DO48737 52 years, male, NA, stage:1, alive, 720 days 948.1
DO48706 72 years, male, NA, stage:2, alive, 870 days 945.2
DO45235 68 years, female, NA, stage:1, alive, 900 days 943.4
DO23536 56 years, male, NA, stage:2, alive, 930 days 942.7
DO48704 68 years, female, NA, stage:3, alive, 750 days 942.6
DO23549 74 years, male, NA, stage:3, alive, 990 days 940.0
DO45131 53 years, male, NA, stage:4, dead, 360 days 938.1
DO45173 63 years, male, NA, stage:3, alive, 1170 days 930.1
DO50804 81 years, male, NA, stage:2, alive, 720 days 927.6
DO45117 73 years, female, NA, stage:2, dead, 1110 days 926.1
DO50803 62 years, female, NA, stage:1, alive, 540 days 918.9
DO48746 76 years, male, NA, stage:3, alive, 570 days 918.9
DO45181 84 years, female, NA, stage:2, alive, 1200 days 912.2
DO23539 77 years, male, NA, stage:1, alive, 1110 days 907.1
DO23546 63 years, male, NA, stage:2, alive, 1050 days 904.7
DO50774 68 years, female, NA, stage:2, alive, 720 days 898.4
DO45229 74 years, male, NA, stage:1, alive, 990 days 891.9
DO23543 63 years, male, NA, stage:2, alive, 1020 days 889.5
DO23541 65 years, male, NA, stage:2, alive, 930 days 886.8
DO45149 70 years, female, NA, stage:2, alive, 1260 days 884.4
DO50825 70 years, male, NA, stage:2, alive, 390 days 881.6
DO45201 49 years, male, NA, stage:1, alive, 900 days 880.7
DO50859 77 years, male, NA, stage:2, alive, 180 days 875.8
DO45123 78 years, female, NA, stage:2, dead, 570 days 861.9
DO23548 78 years, female, NA, stage:1, alive, 840 days 857.0
DO48733 72 years, male, NA, stage:2, alive, 600 days 856.5
DO23538 67 years, male, NA, stage:2, alive, 450 days 854.2
DO45257 46 years, male, NA, stage:3, alive, 810 days 850.3
DO48727 81 years, female, NA, stage:2, dead, 390 days 842.6
DO45193 68 years, female, NA, stage:4, dead, 120 days 841.9
DO50799 66 years, female, NA, stage:2, alive, 540 days 841.0
DO45137 38 years, male, NA, stage:1, alive, 1320 days 831.7
DO50817 75 years, male, NA, stage:2, alive, 390 days 824.2
DO45191 61 years, female, NA, stage:2, alive, 1200 days 816.5
DO23527 72 years, male, NA, stage:1, alive, 1050 days 816.0
DO23512 60 years, male, NA, stage:1, alive, 1260 days 813.5
DO50822 66 years, male, NA, stage:2, alive, 510 days 797.8
DO50857 72 years, male, NA, stage:2, alive, 210 days 796.3
DO45133 64 years, male, NA, stage:3, dead, 660 days 792.7
DO50850 74 years, male, NA, stage:3, alive, 720 days 773.6
DO50814 83 years, male, NA, stage:3, alive, 420 days 767.6
DO45094 76 years, male, NA, stage:3, alive, 1650 days 766.7
DO45197 51 years, male, NA, stage:2, alive, 1170 days 759.4
DO45099 46 years, male, NA, stage:3, alive, 1590 days 742.4
DO45091 56 years, male, NA, stage:2, dead, 1320 days 741.6
DO45163 76 years, male, NA, stage:2, alive, 960 days 741.2
DO48716 71 years, male, NA, stage:2, alive, 720 days 735.7
DO23531 78 years, female, NA, stage:3, alive, 900 days 724.6
DO227801 77 years, female, NA, stage:1, alive, 660 days 720.4
DO48760 70 years, female, NA, stage:2, alive, 690 days 714.5
DO45175 74 years, male, NA, stage:2, alive, 1140 days 705.0
DO45265 73 years, male, NA, stage:3, alive, 1020 days 699.9
DO45215 65 years, male, NA, stage:2, alive, 1170 days 692.7
DO45093 71 years, male, NA, stage:2, dead, 720 days 692.5
DO227643 79 years, male, NA, stage:2, alive, 1260 days 685.7
DO23551 73 years, male, NA, stage:3, dead, 150 days 662.6
DO48674 80 years, male, NA, stage:2, alive, 1260 days 649.6
DO48682 72 years, female, NA, stage:3, dead, 120 days 646.9
DO50815 62 years, male, NA, stage:3, alive, 150 days 646.8
DO48751 68 years, male, NA, stage:2, dead, 480 days 643.3
DO45171 56 years, male, NA, stage:3, alive, 600 days 641.6
DO45217 69 years, female, NA, stage:3, dead, 270 days 639.8
DO23534 60 years, male, NA, stage:2, alive, 840 days 636.6
DO45247 31 years, female, NA, stage:2, alive, 210 days 615.9
DO50844 75 years, male, NA, stage:4, alive, 300 days 615.9
DO48693 71 years, male, NA, stage:2, alive, 900 days 606.7
DO45113 58 years, male, NA, stage:3, alive, 1560 days 593.1
DO45195 62 years, male, NA, stage:1, alive, 390 days 566.1
DO23544 67 years, male, NA, stage:2, alive, 960 days 565.7
DO50793 76 years, male, NA, stage:4, alive, 540 days 563.8
DO45169 74 years, male, NA, stage:3, alive, 1350 days 553.5
DO50845 72 years, male, NA, stage:3, alive, 210 days 543.2
DO45239 42 years, male, NA, stage:2, alive, 870 days 517.3
DO48721 58 years, female, NA, stage:1, alive, 900 days 502.6
DO23511 83 years, female, NA, stage:3, dead, 180 days 496.6
DO45105 61 years, male, NA, stage:1, alive, 1680 days 469.9
DO45125 58 years, male, NA, stage:3, alive, 1680 days 468.7
DO23517 62 years, male, NA, stage:2, alive, 1200 days 442.1
DO23540 73 years, male, NA, stage:1, alive, 750 days 400.8
DO45241 49 years, male, NA, stage:1, alive, 1080 days 395.4
DO45101 63 years, male, NA, stage:2, alive, 1680 days 373.5
DO45107 63 years, female, NA, stage:2, alive, 1710 days 368.2
DO50816 63 years, male, NA, stage:2, alive, 390 days 362.5
DO23532 71 years, female, NA, stage:1, alive, 960 days 322.7
DO45227 57 years, female, NA, stage:2, alive, 1020 days 315.6
DO45167 67 years, male, NA, stage:2, dead, 1440 days 280.8
Show allShow less
LIVER HEPATOCELLULAR CARCINOMA - Protein relative expression (CPTAC)
Number of samples 330
Samples
Sample ID Sample type nRPX
192 Normal 0.7
311 Tumor 0.7
536 Normal 0.5
917 Tumor 0.5
223 Tumor 0.5
444 Normal 0.5
185 Tumor 0.5
1045 Tumor 0.5
498 Normal 0.4
881 Tumor 0.4
268 Normal 0.3
224 Normal 0.3
478 Normal 0.3
852 Normal 0.3
421 Tumor 0.3
982 Normal 0.3
447 Tumor 0.3
817 Tumor 0.3
124 Normal 0.3
916 Normal 0.3
434 Normal 0.3
126 Normal 0.3
188 Normal 0.3
813 Tumor 0.3
883 Tumor 0.3
445 Tumor 0.3
455 Tumor 0.3
814 Normal 0.3
878 Normal 0.3
297 Tumor 0.2
1028 Normal 0.2
1044 Normal 0.2
816 Normal 0.2
627 Tumor 0.2
563 Tumor 0.2
672 Normal 0.2
823 Tumor 0.2
635 Tumor 0.2
975 Tumor 0.2
416 Normal 0.2
448 Normal 0.2
913 Tumor 0.2
516 Normal 0.2
572 Normal 0.2
284 Normal 0.2
785 Tumor 0.2
386 Normal 0.2
412 Normal 0.2
538 Normal 0.2
778 Normal 0.2
214 Normal 0.2
331 Tumor 0.2
146 Normal 0.2
976 Normal 0.2
384 Normal 0.2
344 Normal 0.2
744 Normal 0.2
212 Normal 0.2
461 Tumor 0.2
868 Normal 0.2
857 Tumor 0.2
671 Tumor 0.2
786 Normal 0.2
958 Normal 0.1
195 Tumor 0.1
492 Normal 0.1
137 Tumor 0.1
777 Tumor 0.1
924 Normal 0.1
528 Normal 0.1
884 Normal 0.1
642 Normal 0.1
332 Normal 0.1
716 Normal 0.1
364 Normal 0.1
713 Tumor 0.1
723 Tumor 0.1
228 Normal 0.1
943 Tumor 0.1
818 Normal 0.1
213 Tumor 0.1
874 Normal 0.1
984 Normal 0.1
283 Tumor 0.1
312 Normal 0.1
375 Tumor 0.1
914 Normal 0.1
354 Normal 0.1
866 Normal 0.1
636 Normal 0.1
882 Normal 0.1
471 Tumor 0.1
715 Tumor 0.1
394 Normal 0.1
142 Normal 0.1
721 Tumor 0.1
515 Tumor 0.1
443 Tumor 0.1
524 Normal 0.1
738 Normal 0.1
218 Normal 0.1
433 Tumor 0.1
343 Tumor 0.1
327 Tumor 0.1
722 Normal 0.1
685 Tumor 0.1
863 Tumor 0.1
954 Normal 0.1
472 Normal 0.1
262 Normal 0.1
698 Normal 0.1
714 Normal 0.0
388 Normal 0.0
341 Tumor 0.0
446 Normal 0.0
921 Tumor 0.0
474 Normal 0.0
432 Normal 0.0
138 Normal 0.0
468 Normal 0.0
423 Tumor 0.0
527 Tumor 0.0
513 Tumor 0.0
286 Normal 0.0
546 Normal 0.0
422 Normal 0.0
277 Tumor 0.0
1032 Normal 0.0
366 Normal 0.0
352 Normal 0.0
686 Normal 0.0
912 Normal 0.0
465 Tumor 0.0
1022 Normal 0.0
272 Normal 0.0
628 Normal 0.0
211 Tumor 0.0
728 Normal 0.0
968 Normal 0.0
187 Tumor 0.0
112 Tumor 0.0
978 Normal 0.0
956 Normal 0.0
514 Normal 0.0
427 Tumor 0.0
415 Tumor 0.0
574 Normal 0.0
925 Tumor 0.0
141 Tumor 0.0
697 Tumor 0.0
1021 Tumor 0.0
426 Normal 0.0
615 Tumor 0.0
396 Normal 0.0
414 Normal 0.0
742 Normal 0.0
395 Tumor 0.0
568 Normal 0.0
428 Normal 0.0
298 Normal 0.0
966 Normal 0.0
392 Normal 0.0
481 Tumor 0.0
666 Normal 0.0
357 Tumor 0.0
618 Normal 0.0
696 Normal 0.0
462 Normal 0.0
558 Normal 0.0
362 Normal 0.0
545 Tumor 0.0
196 Normal 0.0
456 Normal 0.0
424 Normal 0.0
1026 Normal 0.0
867 Tumor 0.0
328 Normal 0.0
525 Tumor 0.0
662 Normal 0.0
952 Normal 0.0
746 Normal 0.0
756 Normal 0.0
363 Tumor 0.0
873 Tumor 0.0
944 Normal 0.0
162 Normal 0.0
186 Normal -0.1
136 Normal -0.1
172 Normal -0.1
145 Tumor -0.1
938 Normal -0.1
376 Normal -0.1
111 Normal -0.1
494 Normal -0.1
383 Tumor -0.1
477 Tumor -0.1
114 Normal -0.1
824 Normal -0.1
534 Normal -0.1
923 Tumor -0.1
232 Normal -0.1
356 Normal -0.1
355 Tumor -0.1
1042 Normal -0.1
922 Normal -0.1
467 Tumor -0.1
727 Tumor -0.1
222 Normal -0.1
1015 Tumor -0.1
1027 Tumor -0.1
365 Tumor -0.1
488 Normal -0.1
217 Tumor -0.1
278 Normal -0.1
918 Normal -0.1
616 Normal -0.1
864 Normal -0.1
368 Normal -0.1
977 Tumor -0.1
518 Normal -0.1
342 Normal -0.1
148 Normal -0.1
132 Normal -0.1
647 Tumor -0.1
641 Tumor -0.1
258 Normal -0.1
413 Tumor -0.1
564 Normal -0.1
482 Normal -0.1
385 Tumor -0.1
862 Normal -0.1
858 Normal -0.1
231 Tumor -0.1
755 Tumor -0.1
466 Normal -0.1
452 Normal -0.1
191 Tumor -0.1
664 Normal -0.1
1016 Normal -0.1
963 Tumor -0.1
436 Normal -0.1
127 Tumor -0.1
358 Normal -0.2
911 Tumor -0.2
128 Normal -0.2
353 Tumor -0.2
221 Tumor -0.2
464 Normal -0.2
135 Tumor -0.2
361 Tumor -0.2
964 Normal -0.2
983 Tumor -0.2
271 Tumor -0.2
493 Tumor -0.2
737 Tumor -0.2
483 Tumor -0.2
877 Tumor -0.2
1046 Normal -0.2
147 Tumor -0.2
161 Tumor -0.2
526 Normal -0.2
617 Tumor -0.2
131 Tumor -0.2
955 Tumor -0.2
451 Tumor -0.2
1014 Normal -0.2
425 Tumor -0.2
743 Tumor -0.2
1031 Tumor -0.2
926 Normal -0.2
567 Tumor -0.2
648 Normal -0.2
535 Tumor -0.2
554 Normal -0.2
981 Tumor -0.2
953 Tumor -0.2
661 Tumor -0.3
393 Tumor -0.3
314 Normal -0.3
497 Tumor -0.3
484 Normal -0.3
724 Normal -0.3
285 Tumor -0.3
745 Tumor -0.3
851 Tumor -0.3
491 Tumor -0.3
695 Tumor -0.3
967 Tumor -0.3
113 Tumor -0.3
557 Tumor -0.3
951 Tumor -0.3
1043 Tumor -0.3
261 Tumor -0.3
171 Tumor -0.3
861 Tumor -0.3
915 Tumor -0.3
387 Tumor -0.3
257 Tumor -0.3
313 Tumor -0.3
523 Tumor -0.3
815 Tumor -0.3
571 Tumor -0.4
665 Tumor -0.4
553 Tumor -0.4
865 Tumor -0.4
1041 Tumor -0.4
573 Tumor -0.4
411 Tumor -0.4
463 Tumor -0.4
267 Tumor -0.4
741 Tumor -0.4
1025 Tumor -0.4
125 Tumor -0.4
937 Tumor -0.4
351 Tumor -0.5
435 Tumor -0.5
663 Tumor -0.5
517 Tumor -0.5
533 Tumor -0.5
367 Tumor -0.5
431 Tumor -0.5
391 Tumor -0.5
227 Tumor -0.5
473 Tumor -0.6
957 Tumor -0.6
123 Tumor -0.6
487 Tumor -0.6
965 Tumor -0.6
1013 Tumor -0.7
537 Tumor -0.7
Show allShow less
LIVER CANCER - Protein expressioni

A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.

Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

 

Antibody stainingi

Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.

Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.


Antibody HPA046859

Antibody HPA063034
 Staining
  High
  Medium
  Low
  Not detected
 Intensity
  Strong
  Moderate
  Weak
  Negative
 Quantity
  >75%
  75%-25%
  <25%
  None
 Location
  Nuclear
  Cytoplasmic/membranous
  Cytoplasmic/membranous,nuclear
  None
Carcinoma, Hepatocellular, NOS
Cholangiocarcinoma

Contact

  • NEWS ARTICLES
  • PRESS ROOM

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.


contact@proteinatlas.org